{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:43:05Z","timestamp":1785328985144,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Institute of Pharmacology PAS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12640-017-9798-6","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T06:00:11Z","timestamp":1503640811000},"page":"474-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies"],"prefix":"10.1007","volume":"33","author":[{"given":"Justyna","family":"Brodowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Przegali\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"key":"9798_CR1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","volume":"29","author":"SK Abbott","year":"2014","unstructured":"Abbott SK, Li H, Mu\u00f1oz SS, Knoch B, Batterham M, Murphy KE, Halliday GM, Garner B (2014) Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease. Mov Disord 29:518\u2013526","journal-title":"Mov Disord"},{"key":"9798_CR2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer\u2019s disease. Lancet 377:1019\u20131031","journal-title":"Lancet"},{"key":"9798_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2014.00331","volume":"5","author":"N Beckmann","year":"2014","unstructured":"Beckmann N, Sharma D, Gulbins E, Becker KA, Edelmann B (2014) Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons. Front Physiol 5:1\u201314","journal-title":"Front Physiol"},{"key":"9798_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2009.07.051","volume":"463","author":"L Bryant","year":"2010","unstructured":"Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci C, Esposito E, Mazzon E, Petrusca DN, Salvemini D (2010) Spinal ceramide and neuronal apoptosis in morphine Antinociceptive tolerance. Neurosci Lett 463:49\u201353","journal-title":"Neurosci Lett"},{"key":"9798_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","volume":"4","author":"C Caddy","year":"2014","unstructured":"Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK (2014) Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Ad Psychopharmacol 4:75\u201399","journal-title":"Ther Ad Psychopharmacol"},{"key":"9798_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5604\/17322693.999024","volume":"66","author":"H Car","year":"2012","unstructured":"Car H, \u017bendzian-Piotrowska M, Fiedorowicz A, Prokopiuk S, Sadowska A, Kurek K (2012) The role of ceramides in selected brain pathologies: ischemia\/hypoxia, Alzheimer disease. Postepy Hig Med Dosw 66:295\u2013303","journal-title":"Postepy Hig Med Dosw"},{"key":"9798_CR7","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1113\/jphysiol.2011.209494","volume":"589","author":"JO Col\u00f3n-S\u00e1ez","year":"2011","unstructured":"Col\u00f3n-S\u00e1ez JO, Yakel JL (2011) The \u03b17 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane. J Physiol 589:3163\u20133174","journal-title":"J Physiol"},{"key":"9798_CR8","first-page":"442","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease. J Neurol 311:442\u2013449","journal-title":"J Neurol"},{"key":"9798_CR9","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101:2070\u20132075","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9798_CR10","doi-asserted-by":"crossref","unstructured":"Ebel P, Imgrund S, Vom Dorp K, Hofmann K, Maier H, Drake H, Degen J, D\u00f6rmann P, Eckhardt M, Franz T. Willecke K (2014) Ceramide synthase 4 deficiency in mice causes lipid alterations in sebum and results in alopecia. Biochem J 461:147\u2013158","DOI":"10.1042\/BJ20131242"},{"key":"9798_CR11","doi-asserted-by":"crossref","first-page":"21433","DOI":"10.1074\/jbc.M113.479907","volume":"288","author":"P Ebel","year":"2013","unstructured":"Ebel P, Vom Dorp K, Petrasch-Parwez E, Zlomuzica A, Kinugawa K, Mariani J, Minich D, Ginkel C, Welcker J, Degen J, Eckhardt M, Dere E, D\u00f6rmann P, Willecke K (2013) Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities. J Biol Chem 288:21433\u201321447","journal-title":"J Biol Chem"},{"key":"9798_CR12","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jalz.2014.08.103","volume":"10","author":"K Fargo","year":"2014","unstructured":"Fargo K (2014) Alzheimer\u2019s association report: 2014 Alzheimer's disease facts and figures. Alzheimers Dement 10:e47\u2013e92","journal-title":"Alzheimers Dement"},{"key":"9798_CR13","unstructured":"Garrett RH, Grisham CM (2012) Biochemistry. Brooks Cole, 5 edition"},{"key":"9798_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1\u201323","journal-title":"Adv Exp Med Biol"},{"key":"9798_CR15","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","volume":"287","author":"C Ginkel","year":"2012","unstructured":"Ginkel C, Hartmann D, Vom Dorp K, Zlomuzica A, Farwanah H, Eckhardt M, Sandhoff R, Degen J, Rabionet M, Dere E, D\u00f6rmann P, Sandhoff K, Willecke K (2012) Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes. J Biol Chem 287:41888\u201341902","journal-title":"J Biol Chem"},{"key":"9798_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0014-5793(02)03482-8","volume":"531","author":"FM Goi","year":"2002","unstructured":"Goi FM, Alonso A (2002) Sphingomyelinases: enzymology and membrane activity. FEBS Lett 531:38\u201346","journal-title":"FEBS Lett"},{"key":"9798_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0074-7742(06)78002-3","volume":"78","author":"Y Goto","year":"2007","unstructured":"Goto Y, Grace AA (2007) The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol 78:41\u201368","journal-title":"Int Rev Neurobiol"},{"key":"9798_CR18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/add.12899","volume":"110","author":"LR Gowing","year":"2015","unstructured":"Gowing LR, Ali L, Allsop S, Marsden J, Turf EE, Wes R, Witton J (2015) Global statistics on addictive behaviours: 2014 status report. Addiction 110:904\u2013919","journal-title":"Addiction"},{"key":"9798_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0014-5793(04)00211-X","volume":"562","author":"A G\u00f3mez-Mu\u00f1oz","year":"2004","unstructured":"G\u00f3mez-Mu\u00f1oz A (2004) Ceramide-1-phosphate: a novel regulator of cell activation. FEBS Lett 562:5\u201310","journal-title":"FEBS Lett"},{"key":"9798_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0014-5793(03)00197-2","volume":"539","author":"A G\u00f3mez-Mu\u00f1oz","year":"2003","unstructured":"G\u00f3mez-Mu\u00f1oz A, Kong J, Salh B, Steinbrecher UP (2003) Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett 539:56\u201360","journal-title":"FEBS Lett"},{"key":"9798_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1194\/jlr.M300158-JLR200","volume":"45","author":"A G\u00f3mez-Mu\u00f1oz","year":"2004","unstructured":"G\u00f3mez-Mu\u00f1oz A, Kong JY, Salh B, Steinbrecher UP (2004) Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45:99\u2013105","journal-title":"J Lipid Res"},{"key":"9798_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.23.2.jnp1","volume":"23","author":"PD Gracia-Garcia","year":"2011","unstructured":"Gracia-Garcia PD, Rao V, Haughey NJ, Venkata Ratnam Bandaru V, Smith G, Rosenberg PB, Lobo A, Lyketsos CG, Mielke MM (2011) Plasma ceramides are elevated in depression. J Neuropsychiatry Clin Neurosci 23:1\u20135","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9798_CR23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","volume":"19","author":"E Gulbins","year":"2013","unstructured":"Gulbins E, Palmada M, Reichel M, L\u00fcth A, B\u00f6hmer C, Amato D, M\u00fcller CP, Tischbirek CH, Groemer TW, Tabatabai G, Becker KA, Tripal P, Staedtler S, Ackermann TF, van Brederode J, Alzheimer C, Weller M, Lang UE, Kleuser B, Grassm\u00e9 H, Kornhuber J (2013) Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med 19:934\u2013938","journal-title":"Nat Med"},{"key":"9798_CR24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong C-X, Schuchman EH (2010) Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol Aging 31:398\u2013408","journal-title":"Neurobiol Aging"},{"key":"9798_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2004.05.042","volume":"1018","author":"H Hisaki","year":"2004","unstructured":"Hisaki H, Shimasaki H, Ueta N, Kubota M, Nakane M, Nakagomi T, Tamura A, Masuda H (2004) In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death. Brain Res 1018:73\u201377","journal-title":"Brain Res"},{"key":"9798_CR26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jnc.13537","volume":"137","author":"JP Huston","year":"2016","unstructured":"Huston JP, Kornhuber J, M\u00fchle C, Japtok L, Komorowski M, Mattern C, Reichel M, Gulbins E, Kleuser B, Topic B, De Souza Silva MA, M\u00fcller CP (2016) A sphingolipid mechanism for behavioral extinction. J Neurochem 137:589\u2013603","journal-title":"J Neurochem"},{"key":"9798_CR27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cellsig.2009.01.026","volume":"21","author":"RW Jenkins","year":"2009","unstructured":"Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21:836\u2013846","journal-title":"Cell Signal"},{"key":"9798_CR28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/hmg\/ddr494","volume":"21","author":"R Jennemann","year":"2012","unstructured":"Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, Rothermel U, Bayerle A, van der Hoeven F, Imgrund S, Kirsch J, Nickel W, Willecke K, Riezman H, Gr\u00f6ne HJ, Sanddhoff R (2012) Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 21:586\u2013608","journal-title":"Hum Mol Genet"},{"key":"9798_CR29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/WNR.0b013e3283571757","volume":"23","author":"JK Ritter","year":"2012","unstructured":"Ritter JK, Fang Y, Xia M, Li P-L, Dewey WL (2012) Contribution of acid sphingomyelinase in the periaqueductal gray region to morphine-induced analgesia in mice. Neuroreport 23:780\u2013785","journal-title":"Neuroreport"},{"key":"9798_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(93)90032-C","volume":"49","author":"MS Keshavan","year":"1993","unstructured":"Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C, Morrison S, Menskey H, Allen M (1993) Erythrocyte membrane phospholipids in psychotic patients. Psychiatry Res 49:89\u201395","journal-title":"Psychiatry Res"},{"key":"9798_CR31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2016.04.001","volume":"63","author":"A Kihara","year":"2016","unstructured":"Kihara A (2016) Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides. Prog Lipid Res 63:50\u201369","journal-title":"Prog Lipid Res"},{"key":"9798_CR32","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010\u20131018","journal-title":"Cell Signal"},{"key":"9798_CR33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00702-005-0374-5","volume":"112","author":"J Kornhuber","year":"2005","unstructured":"Kornhuber J, Medlin A, Bleich S, JendrossekV HAW, Wiltfang J, Gulbins E (2005) High activity of acid sphingomyelinase in major depression. J Neural Transm 112:1583\u20131590","journal-title":"J Neural Transm"},{"key":"9798_CR34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tips.2014.04.003","volume":"35","author":"J Kornhuber","year":"2014","unstructured":"Kornhuber J, M\u00fcller CP, Becker KA, Reichel M, Gulbins E (2014) The ceramide system as a novel antidepressant target. Trends Pharmacol Sci 35:293\u2013304","journal-title":"Trends Pharmacol Sci"},{"key":"9798_CR35","doi-asserted-by":"crossref","first-page":"e23852","DOI":"10.1371\/journal.pone.0023852","volume":"6","author":"J Kornhuber","year":"2011","unstructured":"Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, M\u00fchle C, Terfloth L, Groemer YW, Spitzer GM, Liedl KR, Gulbins E, Tripal P (2011) Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One 6:e23852","journal-title":"PLoS One"},{"key":"9798_CR36","first-page":"707","volume":"396","author":"J Kornhuber","year":"2015","unstructured":"Kornhuber J, Rhein C, M\u00fcller CP, M\u00fchle C (2015) Secretory sphingomyelinase in health and disease 396:707\u2013736","journal-title":"Secretory sphingomyelinase in health and disease"},{"key":"9798_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000315101","volume":"26","author":"J Kornhuber","year":"2010","unstructured":"Kornhuber J, Tripal P, Reichel M, M\u00fchle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E (2010) Functional inhibitors of acid sphingomyelinase (FIASMAS): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26:9\u201320","journal-title":"Cell Physiol Biochem"},{"key":"9798_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","volume":"559","author":"M K\u00f6lzer","year":"2004","unstructured":"K\u00f6lzer M, Werth N, Sandhoff K (2004) Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Lett 559:96\u201398","journal-title":"FEBS Lett"},{"key":"9798_CR39","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","volume":"64","author":"S Lahiri","year":"2007","unstructured":"Lahiri S, Futerman AH (2007) The metabolis and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 64:2270\u20132284","journal-title":"Cell Mol Life Sci"},{"key":"9798_CR40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000350094","volume":"31","author":"UE Lang","year":"2013","unstructured":"Lang UE, Borgwardt S (2013) Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 31:761\u2013777","journal-title":"Cell Physiol Biochem"},{"key":"9798_CR41","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20132451","volume":"211","author":"JK Lee","year":"2014","unstructured":"Lee JK, Jin HK, Park MH, Kim B-P, Lee PH, Nakauchi H, Carter JE, He X, Schuchman EH, Bae J-S (2014) Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer\u2019s disease. J Exp Med 211:1551\u20131570","journal-title":"J Exp Med"},{"key":"9798_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, Chen S, Hsu CY (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123\u2013131","journal-title":"J Cell Biol"},{"key":"9798_CR43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.314","volume":"62","author":"M Levy","year":"2010","unstructured":"Levy M, Futerman AH (2010) Mammalian ceramide synthases. IUBMB Life 62:347\u2013356","journal-title":"IUBMB Life"},{"key":"9798_CR44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1159\/000341460","volume":"30","author":"X Li","year":"2012","unstructured":"Li X, Gulbins E, Zhang Y (2012) Oxidative stress triggers Ca2+\u2212dependent lysosome trafficking and activation of acid sphingomyelinase. Cell Physiol Biochem 30:815\u2013826","journal-title":"Cell Physiol Biochem"},{"key":"9798_CR45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2012) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 64:4\u201317","journal-title":"Adv Drug Deliv Rev"},{"key":"9798_CR46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/alcalc\/35.6.569","volume":"35","author":"JJ Liu","year":"2000","unstructured":"Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD (2000) Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 35:569\u2013573","journal-title":"Alcohol Alcohol"},{"key":"9798_CR47","doi-asserted-by":"crossref","first-page":"41128","DOI":"10.1074\/jbc.M206747200","volume":"277","author":"C Luberto","year":"2002","unstructured":"Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277:41128\u201341139","journal-title":"J Biol Chem"},{"key":"9798_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","volume":"70","author":"C Mencarelli","year":"2013","unstructured":"Mencarelli C, Martinez-Martinez P (2013) Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci 70:181\u2013203","journal-title":"Cell Mol Life Sci"},{"key":"9798_CR49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/taap.1996.8029","volume":"142","author":"AH Merrill Jr","year":"1997","unstructured":"Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Rjoseph RT, Voss KA, Wang E (1997) Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208\u2013225","journal-title":"Toxicol Appl Pharmacol"},{"key":"9798_CR50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Bandaru VVR, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M, Varma V, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC (2012) Serum ceramides increase the risk of Alzheimer disease: the Women\u2019s health and aging study II. Neurology 79:633\u2013641","journal-title":"Neurology"},{"key":"9798_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"MM Mielke","year":"2013","unstructured":"Mielke MM, Maetzler W, Haughey NJ, Bandaru VVR, Savica R, Deuschle C, Gasser T, Hauser AK, Gr\u00e4ber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I (2013) Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PLoS One 8:1\u20136","journal-title":"PLoS One"},{"key":"9798_CR52","doi-asserted-by":"crossref","first-page":"17570","DOI":"10.1074\/jbc.M312885200","volume":"279","author":"S Mitsutake","year":"2004","unstructured":"Mitsutake S, Kim TJ, Inagaki Y, Kato M, Yamashita T, Igarashi Y (2004) Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 279:17570\u201317577","journal-title":"J Biol Chem"},{"key":"9798_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20050291","volume":"390","author":"Y Mizutani","year":"2005","unstructured":"Mizutani Y, Kihara A, Igarashi Y (2005) Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J 390:263\u2013271","journal-title":"Biochem J"},{"key":"9798_CR54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S0140525X11000057","volume":"34","author":"CP M\u00fcller","year":"2011","unstructured":"M\u00fcller CP, Schumann G (2011a) Drugs as instruments: a new framework for non-addictive psychoactive drug use. Behav Brain Sci 34:293\u2013310","journal-title":"Behav Brain Sci"},{"key":"9798_CR55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1017\/S0140525X1100135X","volume":"34","author":"CP M\u00fcller","year":"2011","unstructured":"M\u00fcller CP, Schumann G (2011b) To use or not to use: expanding the view on non-addictive psychoactive drug consumption and its implications. Behav Brain Sci 34:328\u2013347","journal-title":"Behav Brain Sci"},{"key":"9798_CR56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00401-016-1658-6","volume":"133","author":"CP M\u00fcller","year":"2016","unstructured":"M\u00fcller CP, Kalinichenko LS, Tiesel J, Witt M, St\u00f6ckl T, Sprenger E, Fuchser J, Beckmann J, Praetner M, Huber SE, Amato D, M\u00fchle C, B\u00fcttner C, Ekici AB, Smaga I, Pomierny-Chamiolo L, Pomierny B, Filip M, Eulenburg V, Gulbins E, Lourdusamy A, Reichel M, Kornhuber J (2016) Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis. Acta Neuropathol 133:463\u2013483","journal-title":"Acta Neuropathol"},{"key":"9798_CR57","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.bbalip.2014.12.014","volume":"1851","author":"CP M\u00fcller","year":"2015","unstructured":"M\u00fcller CP, Reichel M, M\u00fchle C, Rhein C, Gulbins E, Kornhuber J (2015) Brain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta 1851:1052\u20131065","journal-title":"Biochim Biophys Acta"},{"key":"9798_CR58","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/978-1-4614-5836-4_159","volume-title":"Handbook of neurotoxicity","author":"E Niedzielska","year":"2014","unstructured":"Niedzielska E, Rospond B, Pomierny-Chamio\u0142o L, Sadakierska-Chudy A, Filip M (2014) Neurotoxicity: a complex multistage process involving different mechanisms. In: Handbook of neurotoxicity. Springer New York, New York, NY, pp 1525\u20131541"},{"key":"9798_CR59","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","volume":"53","author":"E Niedzielska","year":"2016","unstructured":"Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53:4094\u20134125","journal-title":"Mol Neurobiol"},{"key":"9798_CR60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.psychres.2016.12.039","volume":"250","author":"SR Oliveira","year":"2017","unstructured":"Oliveira SR, Kallaur AP, Lopes J, Colado Sim\u00e3o AN, Vissoci Reiche EM, de Almeida ERD, Morimoto HK, de Carvalho J, de Pereira WL, Alfieri DF, Flauzino T, de Meleck Proen\u00e7a C, Gomes AM, Kaimen-Maciel DR, Maes M (2017) Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: associations with inflammatory and oxidative stress biomarkers and uric acid. Psychiatry Res 250:113\u2013120","journal-title":"Psychiatry Res"},{"key":"9798_CR61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mp.2015.14","volume":"21","author":"TG Oliveira","year":"2016","unstructured":"Oliveira TG, Chan RB, Bravo FV, Miranda A, Silva RR, Zhou B, Marques F, Pinto V, Cerqueira JJ, Di Paolo G, Sousa N (2016) The impact of chronic stress on the rat brain lipidome. Mol Psychiatry 21:80\u201388","journal-title":"Mol Psychiatry"},{"key":"9798_CR62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/bmb\/lds004","volume":"101","author":"E Palazidou","year":"2012","unstructured":"Palazidou E (2012) The neurobiology of depression. Br Med Bull 101:127\u2013145","journal-title":"Br Med Bull"},{"key":"9798_CR63","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1471-4159.2003.02130.x","volume":"87","author":"M Pascual","year":"2003","unstructured":"Pascual M, Valles SL, Renau-Piqueras J, Guerri C (2003) Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem 87:1535\u20131545","journal-title":"J Neurochem"},{"key":"9798_CR64","first-page":"69","volume":"16","author":"T Pietras","year":"2007","unstructured":"Pietras T (2007) Amyloid beta peptide toxicity and oxidative stress in the pathogenesis of Alzheimer's disease. Postep Psych Neurol 16:69\u201373","journal-title":"Postep Psych Neurol"},{"key":"9798_CR65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang J-T, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684\u2013697","journal-title":"Mol Psychiatry"},{"key":"9798_CR66","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1530-0277.2011.01529.x","volume":"35","author":"M Reichel","year":"2011","unstructured":"Reichel M, Beck J, M\u00fchle C, Rotter A, Bleich S, Gulbins E, Kornhuber J (2011) Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients. Alcohol Clin Exp Res 35:1852\u20131859","journal-title":"Alcohol Clin Exp Res"},{"key":"9798_CR67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, rist factors and biomarkers. Biochem Pharmacol 88:640\u2013651","journal-title":"Biochem Pharmacol"},{"key":"9798_CR68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2016.09.019","volume":"209","author":"C Rhein","year":"2017","unstructured":"Rhein C, Reichel N, Kramer M, Rotter A, Lenz B, M\u00fchle C, Gulbins E, Kornhuber J (2017) Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression. J Affect Disord 209:10\u201315","journal-title":"J Affect Disord"},{"key":"9798_CR69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(02)02727-9","volume":"458","author":"EL Riddle","year":"2003","unstructured":"Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE (2003) Ceramide-induced alterations in dopamine transporter function. Eur J Pharmacol 458:31\u201336","journal-title":"Eur J Pharmacol"},{"key":"9798_CR70","doi-asserted-by":"crossref","first-page":"43452","DOI":"10.1074\/jbc.M307104200","volume":"278","author":"C Riebeling","year":"2003","unstructured":"Riebeling C, Allegood JC, Wang E, Merrill AH, Futerman AH (2003) Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate Dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 278:43452\u201343459","journal-title":"J Biol Chem"},{"key":"9798_CR71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2007.03.031","volume":"462","author":"M Schenck","year":"2007","unstructured":"Schenck M, Carpinteiro A, Grassm\u00e9 H, Lang F, Gulbins E (2007) Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 462:171\u2013175","journal-title":"Arch Biochem Biophys"},{"key":"9798_CR72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2004.03.019","volume":"56","author":"A Schmitt","year":"2004","unstructured":"Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, Braus DF, Gattaz WF (2004) Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry 56:41\u201345","journal-title":"Biol Psychiatry"},{"key":"9798_CR73","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.febslet.2009.11.083","volume":"584","author":"EH Schuchman","year":"2010","unstructured":"Schuchman EH (2010) Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-pick disease. FEBS Lett 584:1895\u20131900","journal-title":"FEBS Lett"},{"key":"9798_CR74","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/pr800188y","volume":"7","author":"E Schwarz","year":"2008","unstructured":"Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S (2008) High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 7:4266\u20134277","journal-title":"J Proteome Res"},{"key":"9798_CR75","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1471-4159.1993.tb07470.x","volume":"61","author":"R Shinghal","year":"1993","unstructured":"Shinghal R, Scheller RH, Bajjalieh SM (1993) Ceramide 1-phosphate phosphatase activity in brain. J Neurochem 61:2279\u20132285","journal-title":"J Neurochem"},{"key":"9798_CR76","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jnc.13589","volume":"137","author":"S Sonnino","year":"2016","unstructured":"Sonnino S, Prinetti A (2016) The role of sphingolipids in neuronal plasticity of the brain. J Neurochem 137:485\u2013488","journal-title":"J Neurochem"},{"key":"9798_CR77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","volume":"30","author":"D Sulzer","year":"2007","unstructured":"Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson\u2019s disease. Trends Neurosci 30:244\u2013250","journal-title":"Trends Neurosci"},{"key":"9798_CR78","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00249-008-0338-4","volume":"37","author":"S Trapp","year":"2008","unstructured":"Trapp S, Rosania GR, Horobin RW, Kornhuber J (2008) Quantitative modeling of selective lysosomal targeting for drug design. Eur Biophys J 37:1317\u20131328","journal-title":"Eur Biophys J"},{"key":"9798_CR79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.mp.4001269","volume":"8","author":"TM Tzschentke","year":"2003","unstructured":"Tzschentke TM, Schmidt WJ (2003) Glutamatergic mechanisms in addiction. Mol Psychiatry 8:373\u2013382","journal-title":"Mol Psychiatry"},{"key":"9798_CR80","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamem.2006.06.009","volume":"1758","author":"G Echten-Deckert van","year":"2006","unstructured":"van Echten-Deckert G, Herget T (2006) Sphingolipid metabolism in neural cells. Biochim Biophys Acta 1758:1978\u20131994","journal-title":"Biochim Biophys Acta"},{"key":"9798_CR81","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"LL Venda","year":"2010","unstructured":"Venda LL, Cragg SJ, Buchman VL, Wade-Martins R (2010) \u03b1 -Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci 33:559\u2013568","journal-title":"Trends Neurosci"},{"key":"9798_CR82","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejpain.2008.09.008","volume":"13","author":"JL Vonsy","year":"2009","unstructured":"Vonsy JL, Ghandehari J, Dickenson AH (2009) Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain 13:786\u2013793","journal-title":"Eur J Pain"},{"key":"9798_CR83","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/j.1440-1614.2005.01678.x","volume":"39","author":"M Walterfang","year":"2005","unstructured":"Walterfang M, Wood SJ, Velakoulis D, Copolov D, Pantelis C (2005) Diseases of white matter and schizophrenia-like psychosis. Aust N Z J Psychiatry 39:746\u2013756","journal-title":"Aust N Z J Psychiatry"},{"key":"9798_CR84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2016.09.028","volume":"370","author":"Y Xing","year":"2016","unstructured":"Xing Y, Tang Y, Zhao L, Wang Q, Qin W, Ji X, Zhang J, Jia J (2016) Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson\u2019s disease dementia. J Neurol Sci 370:82\u201387","journal-title":"J Neurol Sci"},{"key":"9798_CR85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tra.12239","volume":"16","author":"T Yamaji","year":"2015","unstructured":"Yamaji T, Hanada K (2015) Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins. Traffic 16:101\u2013122","journal-title":"Traffic"},{"key":"9798_CR86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0269881114555252","volume":"29","author":"JW Young","year":"2015","unstructured":"Young JW, Geyer MA (2015) Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J Psychopharmacol 29:178\u2013196","journal-title":"J Psychopharmacol"},{"key":"9798_CR87","doi-asserted-by":"crossref","first-page":"248135","DOI":"10.1155\/2012\/248135","volume":"2012","author":"SA Young","year":"2012","unstructured":"Young SA, Mina JG, Penny PW, Smith TK (2012) Sphingolipid and ceramide homeostasis: potential therapeutic targets. Biochem Res Int 2012:248135","journal-title":"Biochem Res Int"},{"key":"9798_CR88","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bbamem.2006.08.009","volume":"1758","author":"W Zheng","year":"2006","unstructured":"Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, AllegoodJC LY, Peng Q, Ramaraju H, Sullards CM, Cabot M, Merrill AH (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta Biomembr 1758:1864\u20131884","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"9798_CR89","doi-asserted-by":"crossref","unstructured":"Zuo L, Hemmelgarn BT, Chuang CC, Best TM (2015) The role of oxidative stress-induced epigenetic alterations in amyloid-\u03b2 production in Alzheimer\u2019s disease. Oxid Med Cell Longev:604658x","DOI":"10.1155\/2015\/604658"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9798-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T07:29:21Z","timestamp":1692948561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9798"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9798-6","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]}}}